-
Teva, Alvotech obtain FDA OK for Stelara biosimilar
Selarsdi (ustekinumab-aekn) injection for subcutaneous use is for the treatment of moderate to severe plaque psoriasis and for active psoriatic arthritis. -
Taro to hold meetings for approval of merger with Sun Pharmaceutical Industries
If the merger is completed, Taro will become a privately held company and its shares will no longer be listed on the NYSE.